- Home
- EHAB vs ABSI Comparison
EHAB vs ABSI Comparison
Compare EHAB & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHAB
- ABSI
- Stock Information
- Founded
- EHAB 2014
- ABSI 2011
- Country
- EHAB United States
- ABSI United States
- Employees
- EHAB N/A
- ABSI N/A
- Industry
- EHAB Hospital/Nursing Management
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- EHAB Health Care
- ABSI Health Care
- Exchange
- EHAB Nasdaq
- ABSI Nasdaq
- Market Cap
- EHAB 401.6M
- ABSI 353.8M
- IPO Year
- EHAB N/A
- ABSI 2021
- Fundamental
- Price
- EHAB $10.39
- ABSI $2.71
- Analyst Decision
- EHAB Hold
- ABSI Strong Buy
- Analyst Count
- EHAB 3
- ABSI 5
- Target Price
- EHAB $8.50
- ABSI $8.40
- AVG Volume (30 Days)
- EHAB 440.6K
- ABSI 2.9M
- Earning Date
- EHAB 05-07-2025
- ABSI 05-13-2025
- Dividend Yield
- EHAB N/A
- ABSI N/A
- EPS Growth
- EHAB N/A
- ABSI N/A
- EPS
- EHAB N/A
- ABSI N/A
- Revenue
- EHAB $1,032,300,000.00
- ABSI $4,815,000.00
- Revenue This Year
- EHAB $4.66
- ABSI $145.79
- Revenue Next Year
- EHAB $4.99
- ABSI $99.29
- P/E Ratio
- EHAB N/A
- ABSI N/A
- Revenue Growth
- EHAB N/A
- ABSI N/A
- 52 Week Low
- EHAB $6.85
- ABSI $2.01
- 52 Week High
- EHAB $10.79
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- EHAB 65.48
- ABSI 41.72
- Support Level
- EHAB $10.30
- ABSI $2.59
- Resistance Level
- EHAB $10.62
- ABSI $2.84
- Average True Range (ATR)
- EHAB 0.25
- ABSI 0.20
- MACD
- EHAB -0.05
- ABSI -0.01
- Stochastic Oscillator
- EHAB 42.96
- ABSI 10.09
About EHAB Enhabit Inc.
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.